Adult Vaccines Market
The global adult vaccines market is estimated to be valued at USD 32.8 Bn in 2026 and is expected to reach USD 51.6 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.69% from 2026 to 2033. The global adult vaccines market, being a significant segment of the preventive healthcare market, aims at offering immunization solution services to individuals aged 18 years and above. This market segment is vital in the prevention of vaccine-preventable diseases and the reduction of healthcare costs.
Adult vaccines are different in the sense that they offer immunization solution services to individuals based on the risk of acquiring diseases and immunity levels in adults. This market segment offers various immunization solution services, such as influenza, pneumococcal, hepatitis, HPV, meningococcal, and travel vaccines, among other newer vaccines such as shingles and RSV.
The market growth is driven by factors such as the rising awareness of preventive healthcare, the increasing incidence of chronic diseases which compromise immunity, and the widening recommendations for vaccinations by health authorities. The COVID-19 pandemic has also helped raise the awareness and acceptability of adult vaccination, which is further driving the market growth. In addition, the development of new vaccine technologies, including mRNA, is expected to improve the efficacy of vaccines, thereby driving the market growth.
Market Dynamics
The global adult vaccines market is influenced by a number of factors that create a favorable environment for growth. For instance, an aging population is more susceptible to infections like influenza, pneumococcal disease, and shingles. In addition, an increase in diabetes and heart conditions has made adults more susceptible to infections. Government initiatives aimed at cutting healthcare costs and preventive care are also a major influence. Vaccines are also being driven by an increase in international travel and health programs at the workplace. In addition, advances in vaccine technology are making vaccines more effective and accessible to adults.
However, some factors that inhibit growth in this market are vaccine hesitancy, high R&D costs, and regulatory hurdles. In addition, poor healthcare infrastructure in some parts of the world is a major hindrance to growth.
Despite these challenges, some of the opportunities that are available in this market are a growing healthcare infrastructure in emerging markets, a rise in disposable incomes, and an increase in preventive healthcare. For instance, combination vaccines and digital technologies are making vaccines more accessible and effective.
Key Features of the Study
Market Segmentation
Table of Contents
*Browse 32 market data tables and 28 figures on "Adult Vaccines Market” - Global forecast to 2033
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
860519526
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
